GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Mosaic ImmunoEngineering Inc (OTCPK:CPMV) » Definitions » Shiller PE Ratio

CPMV (Mosaic ImmunoEngineering) Shiller PE Ratio : (As of Apr. 26, 2025)


View and export this data going back to . Start your Free Trial

What is Mosaic ImmunoEngineering Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Mosaic ImmunoEngineering Shiller PE Ratio Historical Data

The historical data trend for Mosaic ImmunoEngineering's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mosaic ImmunoEngineering Shiller PE Ratio Chart

Mosaic ImmunoEngineering Annual Data
Trend May15 May16 May17 May18 May19 May20 Dec21 Dec22 Dec23 Dec24
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Mosaic ImmunoEngineering Quarterly Data
Feb20 May20 Aug20 Nov20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Mosaic ImmunoEngineering's Shiller PE Ratio

For the Biotechnology subindustry, Mosaic ImmunoEngineering's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mosaic ImmunoEngineering's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Mosaic ImmunoEngineering's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Mosaic ImmunoEngineering's Shiller PE Ratio falls into.


;
;

Mosaic ImmunoEngineering Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Mosaic ImmunoEngineering's E10 for the quarter that ended in Dec. 2024 is calculated as:

For example, Mosaic ImmunoEngineering's adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=-0.02/133.1571*133.1571
=-0.020

Current CPI (Dec. 2024) = 133.1571.

Mosaic ImmunoEngineering Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201502 0.031 99.032 0.042
201505 -0.671 100.333 -0.891
201508 -0.094 100.548 -0.124
201511 -0.108 100.135 -0.144
201602 -0.667 100.040 -0.888
201605 -0.719 101.355 -0.945
201608 -0.468 101.617 -0.613
201611 1.205 101.829 1.576
201702 -0.388 102.779 -0.503
201705 -0.411 103.256 -0.530
201708 -0.367 103.587 -0.472
201711 -0.440 104.072 -0.563
201802 -0.322 105.052 -0.408
201805 -0.388 106.148 -0.487
201808 -0.267 106.383 -0.334
201811 -0.191 106.338 -0.239
201902 -0.231 106.649 -0.288
201905 -0.313 108.048 -0.386
201908 -0.431 108.245 -0.530
201911 -0.644 108.519 -0.790
202002 -0.127 109.139 -0.155
202005 -0.129 108.175 -0.159
202008 -1.216 109.662 -1.477
202011 -0.790 109.793 -0.958
202103 -0.150 111.754 -0.179
202106 -0.140 114.631 -0.163
202109 -0.150 115.734 -0.173
202112 -0.120 117.630 -0.136
202203 -0.110 121.301 -0.121
202206 -0.130 125.017 -0.138
202209 -0.020 125.227 -0.021
202212 -0.070 125.222 -0.074
202303 -0.060 127.348 -0.063
202306 0.002 128.729 0.002
202309 -0.050 129.860 -0.051
202312 -0.040 129.419 -0.041
202403 -0.040 131.776 -0.040
202406 -0.040 132.554 -0.040
202409 -0.030 133.029 -0.030
202412 -0.020 133.157 -0.020

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Mosaic ImmunoEngineering  (OTCPK:CPMV) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Mosaic ImmunoEngineering Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Mosaic ImmunoEngineering's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Mosaic ImmunoEngineering Business Description

Traded in Other Exchanges
N/A
Address
9114 Adams Avenue, Suite 202, Huntington Beach, CA, USA, 92646
Mosaic ImmunoEngineering Inc is a development-stage biotechnology company focused on bridging immunology and engineering to develop novel immunotherapies to treat and prevent cancer and infectious diseases. It has a single operating segment for the purposes of assessing performance and making operating decisions.
Executives
Robert Baffi director C/O BIOMARIN PHARMACEUTICAL INC., 105 DIGITAL DRIVE, NOVATO CA 94949
Case Western Reserve University 10 percent owner 10900 EUCLID AVENUE, CLEVELAND OH 44106
Steven W King director, officer: President and CEO
Paul J Lytle director, officer: EVP, Chief Financial Officer
Robert L Garnick director C/O PATRIOT SCIENTIFIC, 2038 CORTE DEL NOGAL, SUITE 141, CARLSBAD CA 92011
Nicole Franziska Steinmetz director, officer: Chief Scientific Officer 871 WILBUR AVENUE, SAN DIEGO CA 92019
Dharmesh Mistry director 315 PEMBROKE COURT, SAN RAMON CA 94582
Carlton M Johnson director
Donald E Schrock director C/O INTEGRATED DEVICE TECHNOLOGY, INC., 6024 SILVER CREEK VALLEY ROAD, SAN JOSE CA 95138
Paul R Bibeau officer: VP, Business Development MICROSEMI CORP, 2381 MORSE AVE, IRVINE CA 92614
Frederick C Goerner officer: Chief Executive Officer MICROSEMI CORPORATION, ONE ENTERPRISE, ALISO VIEJO CA 92656
Clifford L Flowers officer: Chief Financial Officer C/O BAKBONE SOFTWARE, INC., 9540 TOWNE CENTRE DRIVE, SUITE 100, SAN DIEGO CA 92121
Harry L Tredennick director 6183 PASEO DEL NORTE #180, CARLSBAD CA 92011
Thomas J Sweeney officer: CFO
Helmut Jr Falk director

Mosaic ImmunoEngineering Headlines

From GuruFocus

Patriot Scientific Corporation Files Quarterly Report

By ACCESSWIRE AccessWire 04-12-2019